title: Type 2 diabetes mellitus in France in 2012: results from the ObEpi survey.
abstract: OBJECTIVE
  This analysis estimates the prevalence of type 2 diabetes mellitus (T2DM) in French adults participating in the ObEpi (obesity epidemiology) 2012 survey and also proposes a description of that population, according to comorbidities, treatments and sociodemographic factors related to the disease.
  
  
  METHODS
  A self-administered questionnaire was posted to 20,000 households from the Kantar Health panel. In total, 25,714 adults aged≥18 years and representative of the French population completed the survey between January and March 2012.
  
  
  RESULTS
  The prevalence of T2DM was 5.5±0.3% (95% CI) in this representative sample of the adult French population. Average age of patients was 65.9 years; 55% were men. Mean body mass index was 29.9kg/m(2) (men: 29.4kg/m(2), women: 30.6 kg/m(2); P<0.01); the prevalence of obesity was 43.1% (men: 39.9%, women: 47.1%; P<0.01). Patient-reported treatments for comorbidities were frequent: high blood pressure, 59.1%; dyslipidaemia, 59.9%; myocardial infarction/angina pectoris, 9.7%; revascularization, 7.8%; heart failure, 7.4%; sleep apnoea, 8.3%; and osteoarthritis, 10.7%. With regards to known treatments, 81.4% of patients were taking oral antidiabetic drugs (OADs), and 15.3% were using insulin therapy. Also, 18.8% of diabetic respondents reported financial hardship.
  
  
  CONCLUSIONS
  T2DM remains a disease of major concern: compared with the non-diabetic population, all parameters surveyed showed unfavourable ratings, particularly for women.
authors.affiliation: Inserm, Center for Research in Epidemiology and Population Health (CESP), U1018, Epidemiology of diabetes, obesity and chronic renal disease, 94807 Villejuif, France; University Paris-Sud, UMRS 1018, 94807 Villejuif, France. Electronic address: ef.eschwege@wanadoo.fr.
authors.forename: E
authors.initials: E
authors.lastname: Eschwege
authors.affiliation: Nutrition Department, hôpital Pitié-Salpêtrière, AP-HP, 75013 Paris, France; Institute of Cardiology Metabolism and Nutrition, ICAN, 75013 Paris, France.
authors.forename: A
authors.initials: A
authors.lastname: Basdevant
authors.affiliation: Kantar Health, 92120 Montrouge, France.
authors.forename: A
authors.initials: A
authors.lastname: Crine
authors.affiliation: Nutrition Department, hôpital Pitié-Salpêtrière, AP-HP, 75013 Paris, France.
authors.forename: C
authors.initials: C
authors.lastname: Moisan
authors.affiliation: Inserm, Center for Research in Epidemiology and Population Health (CESP), U1018, Epidemiology of diabetes, obesity and chronic renal disease, 94807 Villejuif, France; University Paris-Sud, UMRS 1018, 94807 Villejuif, France.
authors.forename: M-A
authors.initials: MA
authors.lastname: Charles
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015897:Comorbidity; D003430:Cross-Sectional Studies; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology*; D005260:Female; D005602:France / Q000453:epidemiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000453:epidemiology*; D015995:Prevalence; D012959:Socioeconomic Factors
keywords: Comorbidity; Epidemiology; Prevalence; Treatment; Type 2 diabetes mellitus